We are live on ! Find out more
NVO

Novo Nordisk
NVO

707 hedge funds and large institutions have $8.87B invested in Novo Nordisk in 2021 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 259 increasing their positions, 210 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 259 | Existing positions reduced: 210

21% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 56

1% more funds holding

Funds holding: 702 → 707 (+5)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

0.5% less ownership

Funds ownership: 15.06% → 14.56% (-0.5%)

7% less capital invested

Capital invested by funds: $9.54B → $8.87B (-$665M)

21% less call options, than puts

Call options by funds: $21.8M | Put options by funds: $27.5M

Holders
707
Holders Change
+5
Holders Change %
+0.71%
% of All Funds
12.41%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
68
Increased
259
Reduced
210
Closed
56
Calls
$21.8M
Puts
$27.5M
Net Calls
-$5.73M
Net Calls Change
-$19.1M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$132M
2
FP
Financial Perspectives
Minnesota
+$40M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$30.3M
4
Capital International Investors
Capital International Investors
California
+$25.2M
5
Millennium Management
Millennium Management
New York
+$25M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$142M
2
F
Folketrygdfondet
Norway
-$101M
3
AAMU
Amundi Asset Management US
Massachusetts
-$48M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$46.5M
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$37.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
RPWA
751
Regent Peak Wealth Advisors
Georgia
– -$15K -434 Closed
HIM
752
Hillsdale Investment Management
Ontario, Canada
– -$10K -280 Closed
LAM
753
Lountzis Asset Management
Pennsylvania
– -$9K -260 Closed
ABC
754
Associated Banc-Corp
Wisconsin
– -$8K -226 Closed
GSAM
755
Grant Street Asset Management
Pennsylvania
– -$7K -200 Closed
BSSFA
756
Baron Silver Stevens Financial Advisors
Florida
– -$6K -180 Closed
IA
757
Inspire Advisors
Idaho
– -$5K -130 Closed
VCG
758
Vantage Consulting Group
Virginia
– -$4K -120 Closed
TI
759
tru Independence
Oregon
– -$4 -104 Closed
BWA
760
BDO Wealth Advisors
Florida
– -$3K -92 Closed
TFGT
761
TS Financial Group (TSFG)
Illinois
– -$3K -76 Closed
AWG
762
Altus Wealth Group
Colorado
– -$3K -74 Closed
27 28 29 30
31

NVO Hedge Fund Activity: Q1 2021 in Review

707 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2021, worth a combined $8.87B — down 7% from $9.54B a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new NVO positions and 56 closed out — a net gain of 12 holders — while 259 added to existing stakes and 210 trimmed.

The largest buyer was BlackRock, adding an estimated $132M. The largest seller was Renaissance Technologies, cutting an estimated $142M.

  • 707 institutional investors held Novo Nordisk (NVO) as of Q1 2021, up from 702 in Q4 2020.
  • Funds reported $8.87B of Novo Nordisk stock for Q1 2021, down 7% quarter-over-quarter.
  • 68 funds opened new Novo Nordisk positions in Q1 2021 and 56 closed out, a net change of +12 holders.
  • The largest Novo Nordisk buyer in Q1 2021 was BlackRock, an estimated $132M added.
  • The largest Novo Nordisk seller in Q1 2021 was Renaissance Technologies, an estimated $142M sold.

Based on aggregated 13F filings for Q1 2021.